News
Public · Published
SI-BONE Is Maintained at Buy by Needham
Needham kept its Buy rating on SI-BONE but cut its price target to $26.00 per share from $27.00, according to ratings actions reported by Benzinga.
Published:
Updated:
What happened
Needham kept its Buy rating on SI-BONE but cut its price target to $26.00 per share from $27.00, according to ratings actions reported by Benzinga.
Confirmed
Global impact / market context
A lower price target means Needham still expects the stock to rise but by less than before, which can reduce expected returns for holders and make some buyers less willing to pay up.
Analyst inference
Analyst price targets are forecasts, not guarantees. A maintained Buy with a slightly lower target suggests views on the company are still positive but somewhat less optimistic than earlier.
Analyst inference
What to watch
- Watch whether other analysts also cut their SI-BONE price targets, since one revision can signal a broader change in expectations. Confirmed
- Watch for any updated company guidance or results releases that explain why Needham lowered its target. Proposed
- Watch whether the stock moves toward the new $26.00 target, which would show investors accepting the revised outlook. Analyst inference
Evidence
- Original source link unavailable